Epithelial Mesenchymal Transition

Overview

Epithelial-mesenchymal transition (EMT) is a cellular program in which polarized epithelial cells lose their cell-cell adhesion and acquire migratory, mesenchymal properties. While essential during embryonic development and wound healing, aberrant EMT activation drives cancer metastasis, organ fibrosis, and barrier dysfunction — including intestinal barrier compromise.

Metal Induction of EMT

Several heavy metals directly trigger EMT through well-characterized signaling pathways. Cadmium activates EMT via TGF-beta/Smad signaling and PI3K/Akt pathways, downregulating E-cadherin and upregulating vimentin and N-cadherin. Nickel induces EMT through HIF-1alpha stabilization under normoxic conditions, mimicking hypoxia. Arsenic promotes EMT through ROS-mediated activation of NF-kB. These metal-induced EMT events link chronic environmental exposure to cancer initiation and progression.

Gut Barrier Relevance

In the intestinal epithelium, partial EMT compromises the tight junction network, increasing permeability. This connects metal exposure to leaky-gut and downstream systemic inflammation. Microbiome-derived signals can either promote EMT (through chronic inflammation and biofilm-associated toxins) or suppress it (through butyrate-mediated maintenance of epithelial phenotype).

The Metal-Microbiome-EMT Triangle

The intersection of metals, microbiome, and EMT reveals a reinforcing cycle: metal exposure induces partial EMT, weakening the barrier; barrier compromise allows microbial translocation and inflammation; inflammation increases metal bioavailability through nutritional immunity disruption, which further promotes EMT. Breaking this cycle requires addressing the metal pressure, not just the microbial consequence.

Cross-References

References (8)

  1. Yuanzhao Xu, Lingyue An, Jiling Xie et al. (2026). Xu 2026 — The Gut-Prostate Axis in Benign Prostatic Hyperplasia: Systematic Review of Microbial Dysbiosis and Pathogenic Mechanisms. BMC Urology. doi:10.1186/s12894-025-02003-2
  2. Lulu Farhana, Pratima Nangia-Makker, Evan Arbit et al. (2016). Bile acid: a potential inducer of colon cancer stem cells. Stem Cell Research & Therapy. doi:10.1186/s13287-016-0439-4
  3. ★Liu L, Chen J, Liu C et al. (2022). Relationships Between Biological Heavy Metals and Breast Cancer: A Systematic Review and Meta-Analysis. Frontiers in Nutrition. doi:10.3389/fnut.2022.838869
  4. Kevin J. Thompson, James N. Ingle, Xiaojiu Tang et al. (2017). Thompson et al. 2017 — A Comprehensive Analysis of Breast Cancer Microbiota and Host Gene Expression. PLOS ONE. doi:10.1371/journal.pone.0188873
  5. XiaoLiang Chen, Feixia Sun, Xuqin Wang et al. (2025). Inflammation, microbiota, and pancreatic cancer. Cancer Cell International. doi:10.1186/s12935-025-03673-6
  6. Sipos A, Ujlaki G, Miko E et al. (2021). The role of the microbiome in ovarian cancer: mechanistic insights into oncobiosis and to bacterial metabolite signaling. Molecular Medicine. doi:10.1186/s10020-021-00295-2
  7. Tarhonska K, Lesicka M, Janasik B et al. (2022). Cadmium and breast cancer - Current state and research gaps in the underlying mechanisms. Toxicology Letters. doi:10.1016/j.toxlet.2022.03.003
  8. Wei Guo, Yuchao Zhang, Shiwei Guo et al. (2021). Tumor microbiome contributes to an aggressive phenotype in the basal-like subtype of pancreatic cancer. Communications Biology. doi:10.1038/s42003-021-02557-5

Related Articles